Brief: Trisalus Life Sciences Inc Files Non-Timely 10-K With SEC
April 2 (Reuters) - TriSalus Life Sciences Inc TLSI.O :
* TRISALUS LIFE SCIENCES INC FILES NON-TIMELY 10-K WITH U.S.
SEC
* TRISALUS LIFE SCIENCES INC - IDENTIFIED ERRORS IN
DETERMINING
ITS STOCK-BASED COMPENSATION EXPENSE FOR 2023
Source text for Eikon: ID:n0001104659-24-042145
Further company coverage: TLSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TriSalus Life Sciences
See all newsTriSalus jumps after FDA clears liver treatment device
Brief: Trisalus Life Sciences Receives FDA Clearance For Trinav Advance
TriSalus Life Sciences Inc reports results for the quarter ended June 30 - Earnings Summary
TriSalus Life Sciences Q2 revenue beats estimates
TriSalus Life Sciences Inc expected to post a loss of 15 cents a share - Earnings Preview